Skip to Content
Authors Suwanabol PA, Kent KC, Liu B
Author Profile(s)
Journal J. Surg. Res. Volume: 167 Issue: 2 Pages: 287-97
Publish Date 2011 May 15
PubMed ID 21324395
PMC ID 3077463

Despite novel surgical therapies for the treatment of atherosclerosis, restenosis continues to be a significant impediment to the long-term success of vascular interventions. Transforming growth factor-beta (TGF-β), a family of cytokines found to be up-regulated at sites of arterial injury, has long been implicated in restenosis; a role that has largely been attributed to TGF-β-mediated vascular fibrosis. However, emerging data indicate that the role of TGF-β in intimal thickening and arterial remodeling, the critical components of restenosis, is complex and multidirectional. Recent advancements have clarified the basic signaling pathway of TGF-β, making evident the need to redefine the precise role of this family of cytokines and its primary signaling pathway, Smad, in restenosis. Unraveling TGF-β signaling in intimal thickening and arterial remodeling will pave the way for a clearer understanding of restenosis and the development of innovative pharmacological therapies.

Full Text Full text available on PubMed Central Copyright © 2017 The Board of Regents of the University of Wisconsin System